143 related articles for article (PubMed ID: 124592)
1. The action of antithrombin III on plasmin and activators of plasminogen.
Crawford GP; Ogston D
Biochim Biophys Acta; 1975 May; 391(1):189-92. PubMed ID: 124592
[No Abstract] [Full Text] [Related]
2. Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen.
Andrade-Gordon P; Strickland S
Biochemistry; 1986 Jul; 25(14):4033-40. PubMed ID: 2943315
[TBL] [Abstract][Full Text] [Related]
3. Activation of human Glu-plasminogen to Glu-plasmin by urokinase in presence of plasmin inhibitors. Streptomyces leupeptin and human plasma alpha1-antitrypsin and antithrombin III (plus heparin).
Summaria L; Boreisha IG; Arzadon L; Robbins KC
J Biol Chem; 1977 Jun; 252(11):3945-51. PubMed ID: 140876
[No Abstract] [Full Text] [Related]
4. Tissue plasminogen activator and urokinase mediate the binding of Glu-plasminogen to plasma fibrin I. Evidence for new binding sites in plasmin-degraded fibrin I.
Harpel PC; Chang TS; Verderber E
J Biol Chem; 1985 Apr; 260(7):4432-40. PubMed ID: 3156857
[TBL] [Abstract][Full Text] [Related]
5. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
Thorsen S; Müllertz S; Suenson E; Kok P
Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
[TBL] [Abstract][Full Text] [Related]
6. Properties of three different molecular forms of the alpha 2 plasmin inhibitor.
Clemmensen I; Thorsen S; Müllertz S; Petersen LC
Eur J Biochem; 1981 Nov; 120(1):105-12. PubMed ID: 6458494
[No Abstract] [Full Text] [Related]
7. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
Müllertz S
Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.
Moroi M; Aoki N
J Biol Chem; 1976 Oct; 251(19):5956-65. PubMed ID: 134998
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of human plasmin by human antithrombin-heparin cofactor.
Highsmith RF; Rosenberg RD
J Biol Chem; 1974 Jul; 249(14):4335-8. PubMed ID: 4276455
[No Abstract] [Full Text] [Related]
10. Conversion of Glu-plasminogen to plasmin by urokinase in the presence of tranexamic acid.
Takada A; Takada Y
Thromb Res; 1981 May; 22(4):437-43. PubMed ID: 6457415
[No Abstract] [Full Text] [Related]
11. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
Lind SE; Smith CJ
Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
[TBL] [Abstract][Full Text] [Related]
12. Effect of individual caseins on plasminogen activation by bovine urokinase-type and tissue-type plasminogen activators.
Politis I; White JH; Zavizion B; Goldberg JJ; Guo MR; Kindstedt P
J Dairy Sci; 1995 Mar; 78(3):484-90. PubMed ID: 7782505
[TBL] [Abstract][Full Text] [Related]
13. Stimulation by heparin of the plasmin-mediated conversion of single-chain to two-chain urokinase-type plasminogen activator.
Lijnen HR; Collen D
Thromb Res; 1986 Sep; 43(6):687-90. PubMed ID: 2945283
[No Abstract] [Full Text] [Related]
14. The inhibition of plasmin by antithrombin III-heparin complex in vitro in human plasma and during streptokinase therapy in man.
Telesforo P; Semeraro N; Verstraete M; Collen D
Thromb Res; 1975 Oct; 7(4):669-76. PubMed ID: 128153
[No Abstract] [Full Text] [Related]
15. The effect of heparin on factor XIa and plasmin.
Rosenberg RD
Thromb Diath Haemorrh; 1975 Feb; 33(1):51-62. PubMed ID: 235160
[No Abstract] [Full Text] [Related]
16. Denatured proteins as cofactors for plasminogen activation.
Machovich R; Owen WG
Arch Biochem Biophys; 1997 Aug; 344(2):343-9. PubMed ID: 9264548
[TBL] [Abstract][Full Text] [Related]
17. Activation of plasminogen to plasmin by a protease associated with the outer membrane of Escherichia coli.
Leytus SP; Bowles LK; Konisky J; Mangel WF
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1485-9. PubMed ID: 6453346
[TBL] [Abstract][Full Text] [Related]
18. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
Rouy D; Anglés-Cano E
Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of plasmin generation in plasma by heparin, low molecular weight heparin, and a covalent antithrombin-heparin complex.
Chang GMT; Atkinson HM; Berry LR; Chan AKC
Blood Coagul Fibrinolysis; 2017 Sep; 28(6):431-437. PubMed ID: 27898513
[TBL] [Abstract][Full Text] [Related]
20. An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture.
Holmberg L; Lecander I; Persson B; Astedt B
Biochim Biophys Acta; 1978 Nov; 544(1):128-37. PubMed ID: 152655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
